1Sandercock P, Gubitz G, Foley P, et al.Antiplatelet therapy for acute ischemic stroke ( Cochrane Review) [ M/CD ].In: The Cochrane Library, Issue 2, 2004.
2Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the International stroke trial. On behalf of the CAST and IST collaborative groups[J]. Stroke, 2000, 31:1240.
3Antithrombotie Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction,and stroke in high risk patients [J]. BMJ,2002,324:71.
4de Schryver ELLM, Algra A, van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease( Cochrane Review) [ M/CD]. In: The Cochrane Library, Issue 2,2004.
5Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials[J]. Stroke, 2000, 31:1770.
6International Stroke Trial Collaborative Group. International Stroke Trial (IST) : a randomized trial of aspirin, subcutaneous heparin,both, or neither among 19435 patients with acute ischemic stroke[J]. Lancet, 1997, 349:1569.
7Saxena R, Lewis S, Berge E, et al. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial [J].Stroke, 2001, 32:2333.
8Liu M, Counsell C, Zhao XL, et al. Fibrinogen depleting agents for acute ischaemic stroke (Cochrane Review ) [ M/CD]. In: The Cochrane Library, Issue 2, 2004.
9Fioravanti M, Yanagi M. Cytidinediphosphocholine ( CDP choline)for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly (Cochrane Review) [M/CD]. In:The Cochrane Library, Issue 2, 2004,
10Vrecer M, Turk S, Drinovec J, et al. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke.Meta-analysis of randomized trials [J]. Int J Clin Pharmacol Ther,2003, 41:567.
